Bipolar Disorder
|
0.320 |
Biomarker
|
disease |
PSYGENET |
Since this receptor is within a potential linkage region, ACTHR/MC-2 could be considered a candidate gene for BP.
|
7485268 |
1995 |
Bipolar Disorder
|
0.320 |
Biomarker
|
disease |
BEFREE |
Investigation of the candidate genes ACTHR and golf for bipolar illness by the transmission/disequilibrium test.
|
9433545 |
1997 |
Bipolar Disorder
|
0.320 |
Biomarker
|
disease |
BEFREE |
Since this receptor is within a potential linkage region, ACTHR/MC-2 could be considered a candidate gene for BP.
|
7485268 |
1995 |
X-linked Adrenal Hypoplasia
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
No mutation was found in the NR0B1 and MC2R genes excluding congenital adrenal hypoplasia and FGD type 1.
|
21274326 |
2010 |
X-linked Adrenal Hypoplasia
|
0.310 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Malignant neoplasm of prostate
|
0.300 |
Biomarker
|
disease |
CTD_human |
Identification of genes potentially involved in the acquisition of androgen-independent and metastatic tumor growth in an autochthonous genetically engineered mouse prostate cancer model.
|
17013881 |
2007 |
Toxic Shock Syndrome
|
0.200 |
Biomarker
|
disease |
RGD |
Metallothionein and zinc metabolism in endotoxin shock rats.
|
2822467 |
1987 |
Testicular adrenal rest tumor
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Testicular adrenal rest tumor
|
0.110 |
Biomarker
|
disease |
BEFREE |
The expression of adrenal cortex specific genes (CYP11B1, CYP11B2, and MC2R) in both TART and adrenal tissue is approximately 1000-10 000 times higher compared to that in testes samples.
|
25485724 |
2015 |
Anorexia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Azoospermia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Hypertrophic Cardiomyopathy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Congenital Hypothyroidism
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Cryptorchidism
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Failure to Thrive
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Hypoglycemic coma
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Precocious Puberty
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Quadriplegia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Aarskog syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
No mutation was found in the NR0B1 and MC2R genes excluding congenital adrenal hypoplasia and FGD type 1.
|
21274326 |
2010 |
Aarskog syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
This is the first report of FGD associated with a compound heterozygous mutation of C21Y and R146H in the MC2R gene.
|
17128565 |
2006 |
Aarskog syndrome
|
0.100 |
Biomarker
|
disease |
BEFREE |
Familial Glucocorticoid deficiency (FGD), in which the adrenal cortex fails to produce glucocorticoids, was first shown to be caused by defects in the receptor for ACTH (MC2R) or its accessory protein (MRAP).
|
23279877 |
2013 |
Aarskog syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mutations in genes encoding either ACTH receptor or melanocortin 2 receptor accessory protein are responsible for the disease in about 50% of cases, named FGD type 1 and type 2, respectively.
|
21701219 |
2011 |
Aarskog syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
In several cases of familial glucocorticoid deficiency (FGD), referred to as FGD type 1, mutations have been described in the coding exon of the adrenocorticotropin receptor (melanonocortin receptor type 2, MC2R) gene.
|
12384787 |
2002 |
Aarskog syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The objective of the study was to characterize a novel MC2R gene mutation in a compound heterozygous patient with FGD phenotype.
|
18492762 |
2008 |
Aarskog syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
FGD has been shown to segregate with mutations in the gene coding for ACTH receptor (MC2R) or melanocortin 2 receptor accessory protein (MRAP), whereas mutations in the triple A syndrome (AAAS, Allgrove syndrome) gene have been found in segregation with triple A syndrome.
|
18426811 |
2008 |